About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
BCRX - BioCryst Pharmaceuti...| Previous Close | $10.92 | Open | $11.08 |
| Volume | 8.55M | Market Cap | 1.939B |
| Yield | Last Dividend |
| BioCryst to Report Fourth Quarter and Fu... | 02/11/21 |
| RESEARCH TRIANGLE PARK, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) ??? BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will r... | |
| CNBC using the #Biowar hashtag (that was... | 02/05/21 |
| CNBC using the #Biowar hashtag (that was created to burn $BCRX shorts) to promote their own stocks ??? #stocks chatter | |
| Is it the right moment for investing in ... | 02/03/21 |
| In less than several weeks, BioCryst Pharmaceuticals (NASDAQ: BCRX) shares have advanced from $7.2 above $12, and the current price stands around $10.... | |
| BCRX Stock: Climbing on FDA Approval - C... | 02/03/21 |
| BCRX stock is screaming for the top after the company announced sNDA approval that will expand its audience and ultimately revenue. | |
| Biocryst gets Japanese approval for here... | 02/02/21 |
| HONG KONG ??? Japan???s Ministry of Health, Labor and Welfare (MHLW) has granted approval for Biocryst Pharmaceuticals Inc.???s Orladeyo (berotralstat... | |
| STAT+: Pharmalittle: Russia???s Covid-19... | 02/02/21 |
| BioCryst Pharmaceuticals surged 39% to a five-year high on Monday as Reddit investors declared a "BioWar" against short-sellers betting against the st... | |
| BCRX Stock: The Short Squeeze & Beyond -... | 02/02/21 |
| BCRX stock is headed up for the second consecutive session as Wall Street Bulls squeeze the shorts. There's more to the story here! | |
| Reddit Army Declares ???BioWar??? as Sho... | 02/01/21 |
| BioCryst Pharmaceuticals Inc. blew past a five-year high as Reddit investors rallied around a call to start a ???#BioWar??? on the heavily-shorted bio... | |
| BCRX Stock: BioCryst Heads up on BlackRo... | 02/01/21 |
| BCRX stock is screaming for the top this morning after BlackRock disclosed ownership. There's more to the story. | |
| BCRX Stock: BioCryst Climbs on Approval ... | 01/22/21 |
| BCRX stock is headed for the top in the market this morning after announcing Japanese approval of ORLADEYO. | |
| Thinking about buying stock in iBio, Flu... | 01/22/21 |
| NEW YORK, Jan. 22, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, FLDM, ATOS, BCRX, and GME. To see how InvestorsO... | |
| BCRX Stock: BioCryst Pharmaceutcials Ann... | 12/16/20 |
| BCRX stock is headed for the top in the market this morning after announcing that ORLADEYO is now commercially available. | |
| BioCryst Pharmaceuticals, Inc. (NASDAQ:B... | 12/16/20 |
| BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) VP Alane P. Barnes sold 13,741 shares of the firm???s stock in a transaction that occurred on Friday, Dec... | |
| BioCryst to Present at JMP Securities He... | 12/11/20 |
| RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will??? | |
| Merrill Lynch Stick to Their Buy Rating ... | 12/08/20 |
| Merrill Lynch Stick to Their Buy Rating for Biocryst Pharmaceuticals | |
| Royalty Pharma Acquires Royalty Interest... | 12/07/20 |
| NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BC... | |
| BioCryst Announces $325 Million of Fundi... | 12/07/20 |
| NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq... | |
| BioCryst Pharma News: Why BCRX Stock Is ... | 12/04/20 |
| BioCryst Pharma (BCRX) news for Friday concerning approval from the FDA for one of its drugs has BCRX stock soaring higher. | |
| Looking Into Biocryst Pharmaceuticals's ... | 12/04/20 |
| In Q3, Biocryst Pharmaceuticals (NASDAQ: BCRX) posted sales of $6.10 million. Earnings were up 11.31%, but Biocryst Pharmaceuticals still reported an ... | |
| FXNEWS24 |Are Options Traders Betting on... | 12/03/20 |
| Are Options Traders Betting on a Big Move in BioCryst Pharmaceuticals (BCRX) Stock? | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily F... | |
| BCRX Awaits FDA Decision, JNJ On Watch, ... | 12/02/20 |
| Today's Daily Dose brings you news about the UK authorizing Pfizer/BioNTech's COVID-19 mRNA vaccine BNT162b2 for emergency use, the anticipated event ... | |
| What Does BioCryst Pharmaceuticals's Deb... | 11/13/20 |
| Over the past three months, shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) decreased by 4.88%. Before we understand the importance of debt, let us ... | |
| BioCryst to Present Data at the 2020 ASH... | 11/12/20 |
| RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that preclinical data on... | |
| BioCryst Pharmaceuticals : MHRA Grants H... | 10/30/20 |
| RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2020 -- BioCryst Pharmaceuticals, Inc. today announced that the United Kingdom???s Medicines and Healthcare pro... | |
| BioCryst Pharmaceuticals (NASDAQ:BCRX) S... | 10/22/20 |
| BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)???s share price traded up 7% during mid-day trading on Thursday . The company traded as high as $3.84 and... | |
| BioCryst Pharmaceuticals (NASDAQ:BCRX) T... | 10/21/20 |
| Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) fell 7.3% during trading on Monday . The company traded as low as $3.54 and last traded at $3.5... | |
| BioCryst Pharmaceuticals, Inc. (BCRX) In... | 09/15/20 |
| The following slide deck was published by BioCryst Pharmaceuticals, Inc. in conjunction with this event.. | |
| Key Takeaways From Our Win In BioCryst P... | 06/30/20 |
| Biocryst Pharmaceuticals is a rare disease player (HAE and Factor D in PNH and other complement mediated diseases), with antiviral kicker (galidesivir... | |
| Moving Average Crossover Alert: BioCryst... | 05/18/20 |
| BioCryst Pharmaceuticals, Inc. (BCRX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on t... | |
| BioCryst (BCRX) to Report Q1 Earnings: W... | 04/29/20 |
| During BioCryst's (BCRX) upcoming Q1 earnings call, investor focus will be on the company's progress with the NDA for its HAE drug, Berotralstat, and ... | |
| Hold rating | 01/22/21 |
| RBC Capital maintains Sector Perform rating and raises Price Target from $7.00 to $9.00 | |
| Date | 2021-02-25 (BMO) | Est. (EPS/Rev.) | ($0.25)/ 17.52M |
| Actual (EPS/Rev.) | $-0.34/ $4.02 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
